Supernus Pharmaceuticals Inc (SUPN.O)

SUPN.O on Consolidated Issue listed on NASDAQ Global Market

8.96USD
27 Aug 2014
Price Change (% chg)

-- (+0.00%)
Prev Close
$8.96
Open
$8.95
Day's High
$9.05
Day's Low
$8.89
Volume
202,807
Avg. Vol
459,571
52-wk High
$11.47
52-wk Low
$5.84

SUPN.O

Chart for SUPN.O

About

Supernus Pharmaceuticals, Inc. (Supernus) is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Supernus is developing several product candidates in neurology and psychiatry to address... (more)

Overall

Beta: --
Market Cap (Mil.): $384.58
Shares Outstanding (Mil.): 42.92
Dividend: --
Yield (%): --

Financials

  SUPN.O Industry Sector
P/E (TTM): -- 32.67 33.58
EPS (TTM): -1.72 -- --
ROI: -61.63 18.00 17.30
ROE: -169.92 18.64 18.05
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $42.60 -0.20
AstraZeneca plc (AZN.L) 4,449.00p -18.50
Eli Lilly and Co (LLY.N) $63.00 +0.19
Shire PLC (SHP.L) 4,894.00p -22.00
Shire PLC (3159084.L) -- --
Smiths Group plc (SMIN.L) 1,319.00p -3.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks